- Overview
- Agenda
- Features
- Justify This Training
- FAQ
Watch Trailer
Agenda
-
Introduction to Gene Therapy
Explores the cellular and genetic basis of disease and examines the application of gene therapy in spinal muscular atrophy, using Zolgensma as a case study.
-
Viral Vector Delivery Options
Examines gene transfer and tissue specificity, focusing on delivery methods, viral vectors, and key factors influencing vector selection, safety, immunogenicity, and dosage.
-
The Gene Therapy Industry
Focuses on the FDA’s regulatory framework and the gene therapy development process for emerging disease targets.
Features
- Closed Captioning in English, Spanish, French, French Canadian, Hindi, Japanese, Korean, Mandarin, Russian, Standard Arabic
- Transcripts in English, Spanish, French, French Canadian, Hindi, Japanese, Korean, Mandarin, Russian, Standard Arabic
- Course materials
- Real-time tracking
- Progress reporting
- Accessibility features
- Corporate account upgrades
- LinkedIn certificate attachment
- Verified certificates
Justify This Training
View our “Justify This Training” checklist and letter to craft a persuasive request that clearly shows the value of Biotech Primer training to your role and your company. This step-by-step guide helps you highlight ROI, align with business goals, and increase your chances of getting this course approved.
FAQ
Our Executive
Certifications
Cannot make our live class? Consider one of our Executive Certifications.

Drug Development Executive Certification
- CPE:13.50 Credits
- Time:10.5 Hours
- Total:12 Courses

Drug Manufacturing Executive Certification
- CPE:14.50 Credits
- Time:10 Hours
- Total:11 Courses


